The success rate of clarithromycin and furazolidone treatment regimen with or without using pyloshot in patients with refractory Helicobacter pylori infectio
Phase 3
- Conditions
- Helicobacter Pylori.
- Registration Number
- IRCT20230827059273N1
- Lead Sponsor
- Ardabil University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 272
Inclusion Criteria
Patients with treatment-resistant Helicobacter pylori infection who still have positive fecal antigen despite treatment.
Exclusion Criteria
Pregnant and lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacter pylori fecal antigen negativity after two months of treatment. Timepoint: H. pylori fecal antigen measurement once two months after the end of treatment. Method of measurement: Stool test.
- Secondary Outcome Measures
Name Time Method